'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'
With around 2 million Covid vaccine doses likely to get wasted in December, leading hospital chains have now started to give it gratis to citizens. Sohini Das and Ruchika Chitravanshi report.
It takes a while to get used to the constant and instant supply of power that is the case with EVs, and handling the S1 Pro when it takes a corner or makes a turn can be tricky, says Pavan Lall.
A nasal vaccine, one expert said, is a "fantastic idea" for two reasons -- one, it can potentially create sterile immunity, and two, it is easy to administer and thus scalable.
While the Q5 is a light driving car that feels like you can easily fling it over and around brooks and brushes and hills and plains, it's also versatile in that its rear seat is as comfy and spacious as you'd expect, says Pavan Lall.
'The global semiconductor shortage has inadvertently provided an immense fillip to the pre-owned car market'
Every M&M car shares a certain DNA which is rugged, with an off-roading quality and built for hard wear and tear. The XUV is all those, but also has a smoother edge for those who want city comfort now offered in competitor vehicles such as the MG Hector, Hyundai Creta, Volkswagen Tiguan and Tata's Harrier, says Pavan Lall.
Experts, however, feel that given the intensity of the second wave and the high single dose coverage, India is in a good position to avoid any drastic wave in the near future.
Tamil Nadu plans parallel programme with unique user IDs
Will syringe shortage puncture India's Covid vaccine plans?
For the longest time the Polo GT had no real competition in terms of its build quality and product positioning. Until now, says Pavan Lall.
Lack of clarity on data-sharing persists, public health experts sceptic about the pilot that was run in six Union territories as benchmark for national roll-out
With cars like the Toyota Corolla and the Honda Civic selling in very small numbers and potentially even being phased out, the Octavia has very little competition, says Pavan Lall.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
This SUV will look as cool in 2030 as it might have in 2010 and ultimately that's what drives the core appeal of Mercedes-Benz and its products -- being classic, says Pavan Lall.
The sudden spike in cases of fever in India has claimed over 100 lives in five states, including UP, MP, Bihar, Haryana, and West Bengal. In UP, Firozabad and Mathura alone have reported 72 cases.
Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.
Volkswagen's new SUV is set to lock horns with half a dozen rivals, says Pavan Lall.
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances